Blinatumomab

(Mfr: AMG)(Conc: 0.125 mcg/mL^b)

Rasburicase

(Mfr: SAA)(Conc: 0.15 mg/mL^b)

Remarks:

Persistent particulate formation when blinatumomab is added to rasburicase; not observed when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷